Guideline Critics Shift Attacks From Beta Blockers To Statins
Forbes
With the release today of updated European and US guidelines the ongoing controversy regarding beta-blockers appears to be resolved.
Source: www.forbes.com
August 4, 2014 by 2012pharmaceutical
Guideline Critics Shift Attacks From Beta Blockers To Statins
Forbes
With the release today of updated European and US guidelines the ongoing controversy regarding beta-blockers appears to be resolved.
Source: www.forbes.com
Leave a Reply